lifesaving tech. BioTech Alert for Mon.

[Lina Deanne]

BIOTECHNOLOGY NEWS.....  MONDAY JULY 25 WATCH
. RADAR ALERT ....RADAR ALERT.....RADAR ALERT.....RADAR ALERT


Pacific Sunset Investments Inc.
SYMBOL: PSIV
CURRENT PRICE: .24
SHORT-TERM:  $1.00

How many times have you heard about this????
adverse drug reactions accounted for more than 2.2 million serious cases and
over 100,000 deaths,

PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV***PSIV

A study published in the Journal of the American Medical Association
reported that adverse drug reactions accounted for more than 2.2 million
serious cases and over 100,000 deaths, making adverse drug reactions (ADRs)
one of the leading causes of hospitalization and death in the United States.

Breaking News for Pacific Sunset Investments

Pacific Sunset Investments Completes Gen ID Acquisition
HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--May 20, 2005--Pacific Sunset
Investments, Inc. ("Pacific Sunset") (OTC:PSiV announced that it has
completed its acquisition of Gen-ID Lab Services, LLC, a California limited
liability corporation specializing in Single Nucleotide Polymorphism
analysis data. In addition, the board of directors of Pacific Sunset has
appointed Douglas Freedman to its board of directors with experience in
marketing. Additionally, the company has appointed Dr. Steve N. Slilaty,
Ph.D., to head an Advisory Board to assist the company with reviewing new
alternatives in the "SNP" field of technology.

Gen ID will provide "SNP" (Single Nucleotide Polymorphism) analysis data.
The results of SNP analysis provide physicians with a more enlightened
choice of drugs and they will also be able to predict the effectiveness of
the drugs for individual patients. The use of an SNP test to help treat
childhood leukemia is currently being used by doctors and hospitals in the
United States.

Dr. Steve Slilaty is President and Chief Scientific Officer of Advanomics
Corporation, a leading-edge biotechnology company focusing on the
identification of disease related molecular targets using advanced
transriptomics technologies, which he recently developed. Dr. Slilaty also
is an Adjunct Professor at the Universite du Quebec in the department of
Microbiology and Biotechnology. Dr. Slilaty has founded three biotechnology
companies, Advanomics Corporation, Quantum Biotechnologies Inc. (now known
as Qbiogene Inc.) and Geneomics One Corporation. In addition, Dr. Slilaty is
one of the pioneers of Gene Therapy, having developed the first Gene
Transfer system in 1983.

(This is a partial clip of the news.  We suggest you go read the whole
release.  Our opinion is, this is important technology.  Go to yahoo or any
financial site and read the news)

CONCLUSION:
adverse drug reactions accounted for more than 2.2 million serious cases and
over 100,000 deaths,  Doesn't this say it all?

 A company to watch!

AGGRESSIVE INVESTORS TAKE NOTE NOW!
PUT Pacific Sunset Investments Inc. PSiV
ON YOUR RADAR SCREENS NOW,
AND WATCH THIS COMPANY STARTING NOW

Disclaimer:
Information within this email contains "forwardlooking statements" within
the meaning of Section 27Aof the Securities Act of 1933 and Section 21B of
the Securities Exchange Act of 1934. Any statements that express or involve
discussions with respect to predictions, expectations, beliefs,
plans, projections, objectives, goals, assumptions or future events or
performance are not statements of historical fact and may be "forward
looking statements". "Forward looking statements" are based on
expectations, estimates and projections at the time the statements are made
that involve a number of risks and uncertainties which could cause actual
results or events to differ materially from those presently anticipated.
Forward looking statements in this action may be identified through the use
of words such as "projects", "foresee", "expects", "will", "anticipates",
"estimates", "believes", "understands" or that by statements indicating
certain actions "may", "could", or "might" occur. Risk factors include
general economic and business conditions, the ability to acquire and develop
specific projects, the ability to fund operations and changes in consumer
and business consumption habits and other factors overwhich the company has
little or no control. The publisher of this newsletter does not represent
that the information contained in this message states all material facts or
does not omit a material fact necessary to make the statements therein not
misleading. All information provided within this email pertaining to
investing, ST0CKs, securities must be understood as information provided and
not investment advice. The publisher of this newsletter advises all readers
and subscribers to seek advice from a registered professional securities
representative before deciding to trade in ST0CKs featured within this
email. None of the material within this report shall be construed as any
kind of investment advice or solicitation. Many of these companies are on
the verge of bankruptcy. You can lose all your money by investing in this
ST0CK. We urge you to read the company's SEC filings now, before you invest.
The publisher of this newsletter is not a registered invstment advisor.
Subscribers should not view information herein as legal, tax, accounting or
investment advice. In compliance with the SecuritiesAct of 1933, Section
17(b), The publisher of this newsletter is contracted to receive six hundred
thousand free trading shares from a third party, not an officer, director or
affiliate shareholder for the circulation of this report. Be aware of an
inherent conflict of interest resulting from such compensation due to the
fact that this is a paid advertisement and is not without bias. The party
that paid us has a position in the ST0CK they will sell at anytime without
notice. This could have a negative impact on the price of the ST0CK, causing
you to lose money. All factual information in this report was gathered from
public sources, including but not limited to SEC filings, Company Websites
and Company Press Releases. The publisher of this newsletter believes this
information to be reliable but can make no guarantee as to its accuracy or
completeness. Use of the material within this email constitutes your
acceptance of these terms.

support him in the polls Mr Faure addressed 
them restating his determination to hold Two former 
US presidents have urged the world not to 
forget victims of the
Indian Ocean tsunami in December and do more 
to assist reconstruction efforts Bill Clinton and George 
Bush Sr were speaking v after visiting a Thai 
village ravaged by the disaster which killed more v 
than 200000 in a 
dozen countries The two former leaders have been 
asked by the White House to raise funds 
to help those affected They will also visit v 
Indonesia Sri Lanka and the Maldives "It's very 
moving I'll never forget this" Mr Bush said 
at a news conference in the Baan Nam 
Khem village just north of the resort of 
Phuket Click here for details of aid donations 
so farHe was speaking 

after a little girl whose mother was killed 
by the tsunami gave him a picture showing 
her village being struck by the giant waves 
Mr Clinton also came 
close to tears after receiving a similar drawing 
from another child in the village which lost 
half of its population at least 2500 people 
I don't think there's ever been a tragedy 
that affected the heartbeat of the American people 
as much as this tsunami has done George v
Bush SrLeaders meet villagers Mr Clinton said that 
those affected by the tsunami should not be v v 
ignored when the cameras had gone "What we v v 
have to do is